KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Cash & Equivalents: 2015-2025

Historic Cash & Equivalents for Nutanix (NTNX) over the last 11 years, with Jul 2025 value amounting to $769.5 million.

  • Nutanix's Cash & Equivalents rose 8.91% to $780.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $780.4 million, marking a year-over-year increase of 8.91%. This contributed to the annual value of $769.5 million for FY2025, which is 17.36% up from last year.
  • Per Nutanix's latest filing, its Cash & Equivalents stood at $769.5 million for FY2025, which was up 17.36% from $655.7 million recorded in FY2024.
  • Over the past 5 years, Nutanix's Cash & Equivalents peaked at $769.5 million during FY2025, and registered a low of $288.9 million during FY2021.
  • Over the past 3 years, Nutanix's median Cash & Equivalents value was $655.7 million (recorded in 2024), while the average stood at $646.0 million.
  • In the last 5 years, Nutanix's Cash & Equivalents declined by 10.29% in 2021 and then surged by 40.50% in 2022.
  • Nutanix's Cash & Equivalents (Yearly) stood at $288.9 million in 2021, then spiked by 40.50% to $405.9 million in 2022, then rose by 26.38% to $512.9 million in 2023, then increased by 27.83% to $655.7 million in 2024, then rose by 17.36% to $769.5 million in 2025.